What's happening
This bill requires managed care providers to cover more prescription drug classes as determined medically necessary by prescribers, with limited exceptions.
Why it matters
Expands the range of protected drug classes. By including more categories like anti-depressant, anti-retroviral, antirejection, seizure, epilepsy, endocrine, hematologic, and immunologic drugs, the bill ensures that people with a wider variety of serious health conditions have guaranteed access to necessary medications.
Empowers prescriber decision-making. The final say on medical necessity for these drugs shifts to the prescribing healthcare provider, not the managed care plan, which can help patients get the treatments their doctors believe are best without as many administrative barriers.
Limits insurer denials, but with key exceptions. While prescriber judgment is largely final, there are carve-outs—managed care providers can still require generic substitution where mandated by law, and can deny coverage if the drug use isn’t FDA-approved or supported by recognized medical references. This balances patient access with some guardrails against inappropriate use.
Repeals conflicting or outdated sections. By removing older statutory language, the bill clarifies and streamlines the rules for both providers and patients, reducing confusion about what drugs are covered and under what circumstances.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Expand Medicaid Drug Coverage
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
503
2023-2024 Regular Sessions
IN SENATE
January 4, 2023
Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the social services law, in relation to coverage for certain prescription drugs; and to repeal certain provisions of such law relating thereto
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 25 of section 364-j of the social services law, as added by section 55 of part D of chapter 56 of the laws of 2012, is amended to read as follows:
25. [Effective January first, two thousand thirteen, notwithstanding] Notwithstanding any provision of law to the contrary, managed care providers shall cover medically necessary prescription drugs in the anti-depressant, anti-retroviral, antirejection, seizure, epilepsy, endocrine, hematologic, immunologic and atypical antipsychotic therapeutic [class] classes, including non-formulary drugs, upon [demonstration] determination by the prescriber under this subdivision. If the prescriber, after consulting with the managed care provider, determines that such drugs, in the prescriber's reasonable professional judgment, are medically necessary and warranted, the prescriber's determination shall be final. However, the prescriber's determination shall not be final: (a) where the drug approved by the managed care provider is a generic drug subject to subparagraph (i) of paragraph (a-1) of subdivision four of section three hundred sixty-five-a of this title (mandatory generic substitution), and even if the prescriber has indicated that the prescription shall be dispensed as written; or (b) if it is for the use of a drug that is not consistent with food and drug administration-approved labeling or supported by one or more official Compendia references, including, but not limited to, the American Hospital Formulary Service (AHFS), the DRUGDEX Drug Information System and the United States Pharmacopeia.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01801-01-3
§ 2. Subdivision 25-a of section 364-j of the social services law is REPEALED.
§ 3. This act shall take effect on the sixtieth day after it shall have become a law; provided that effective immediately, the commissioner of health may make regulations and take other actions necessary to implement this act on that date; and provided, further, that the amendments to section 364-j of the social services law made by section one of this act shall not affect the repeal of such section and shall be deemed repealed therewith.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the social services law, in relation to coverage for certain prescription drugs; and to repeal certain provisions of such law relating thereto
Purpose
Provides coverage for certain medically necessary prescription drugs in Medicaid managed care programs.
Summary of specific provisions
Section 1 amends subdivision 25 of section 364-j of the social services law as it relates to the medicaid managed care program to cover addi- tional classes of medically necessary drugs. This section includes drugs classified as antidepressant, anti-retroviral, anti-rejection, seizure, epilepsy, endocrine, hematologic, and immunologic to be eligible for coverage and allows prescribers to have final say on the medical neces- sity of such medications, except for brand name drugs that have a gener- ic alternative or the drug is not consistent with FDA labeling or not supported by at least one official drug Compendia reference.
Section 2 repeals subdivision 25-a of section 364-j of the social services law as it relates to medicaid managed care programs to cover certain classes of medically necessary drugs which were consolidated into subdivision 25 of section 1 of this bill.
Section 3 is the effective date.
Justification
Current New York State law allows physicians treating patients under the Medicaid feefor-service program to invoke prescriber prevails without extra roadblocks. This bill will ensure that a managed-care Medicaid patient's health care professional has the final say in determining which drug, in certain classes, will be dispensed to the patient unless the drug requires generic substitution or the intended purpose is off- label or not supported by official Compendia. This bill is drafted to respond to the veto message that was issued by the Governor in relation to the 2015 bill S4893.
Legislative history
2015-2016: Similar to S4893, which was vetoed
2017-2018: S6541 Hannon
2019-2020: S1794A / A2799A Gottfried
2021-2022: S1588
Fiscal implications
To be determined
Effective date
On the 60th day after enactment, provided that effective immediately the Commissioner of Health may make regulations necessary to implement the act.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.